These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31387750)

  • 1. Enhanced protective efficacy of Borrelia burgdorferi BB0172 derived-peptide based vaccine to control Lyme disease.
    Hassan WS; Giaretta PR; Rech R; Ollivault-Shiflett M; Esteve-Gasent MD
    Vaccine; 2019 Sep; 37(37):5596-5606. PubMed ID: 31387750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tick-Tattoo: DNA Vaccination Against
    Klouwens MJ; Trentelman JJA; Wagemakers A; Ersoz JI; Bins AD; Hovius JW
    Front Immunol; 2021; 12():615011. PubMed ID: 33717102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicomponent Lyme vaccine: three is not a crowd.
    Brown EL; Kim JH; Reisenbichler ES; Höök M
    Vaccine; 2005 May; 23(28):3687-96. PubMed ID: 15882529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with a Borrelia burgdorferi BB0172-derived peptide protects mice against lyme disease.
    Small CM; Ajithdoss DK; Rodrigues Hoffmann A; Mwangi W; Esteve-Gassent MD
    PLoS One; 2014; 9(2):e88245. PubMed ID: 24505447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Borrelia burgdorferi BbHtrA Protease as a Vaccine Candidate for Lyme Borreliosis in Mice.
    Ullmann AJ; Russell TM; Dolan MC; Williams M; Hojgaard A; Weiner ZP; Johnson BJ
    PLoS One; 2015; 10(6):e0128868. PubMed ID: 26076465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs.
    Scheckelhoff MR; Telford SR; Hu LT
    Vaccine; 2006 Mar; 24(11):1949-57. PubMed ID: 16300863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development.
    Izac JR; Oliver LD; Earnhart CG; Marconi RT
    Vaccine; 2017 May; 35(24):3178-3185. PubMed ID: 28479174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dogs vaccinated with common Lyme disease vaccines do not respond to IR6, the conserved immunodominant region of the VlsE surface protein of Borrelia burgdorferi.
    O'Connor TP; Esty KJ; Hanscom JL; Shields P; Philipp MT
    Clin Diagn Lab Immunol; 2004 May; 11(3):458-62. PubMed ID: 15138170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Borrelia burgdorferi BBA64 protein as a protective immunogen in mice.
    Brandt KS; Patton TG; Allard AS; Caimano MJ; Radolf JD; Gilmore RD
    Clin Vaccine Immunol; 2014 Apr; 21(4):526-33. PubMed ID: 24501342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Surface Epitopes Associated with Protection against Highly Immune-Evasive VlsE-Expressing Lyme Disease Spirochetes.
    Batool M; Caoili SEC; Dangott LJ; Gerasimov E; Ionov Y; Piontkivska H; Zelikovsky A; Waghela SD; Rogovskyy AS
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29866906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Live Attenuated Borrelia burgdorferi Targeted Mutants in an Infectious Strain Background Protect Mice from Challenge Infection.
    Hahn BL; Padmore LJ; Ristow LC; Curtis MW; Coburn J
    Clin Vaccine Immunol; 2016 Aug; 23(8):725-31. PubMed ID: 27335385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating BB0405 as a novel Borrelia afzelii vaccination candidate in Lyme borreliosis.
    Klouwens MJ; Trentelman JJ; Ersoz JI; Nieves Marques Porto F; Sima R; Hajdusek O; Thakur M; Pal U; Hovius JW
    Sci Rep; 2021 Feb; 11(1):4775. PubMed ID: 33637813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA.
    Koide S; Yang X; Huang X; Dunn JJ; Luft BJ
    J Mol Biol; 2005 Jul; 350(2):290-9. PubMed ID: 15935380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against tick-transmitted Lyme disease in dogs vaccinated with a multiantigenic vaccine.
    Straubinger RK; Dharma Rao T; Davidson E; Summers BA; Jacobson RH; Frey AB
    Vaccine; 2001 Oct; 20(1-2):181-93. PubMed ID: 11567763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Factor H-Binding Site of CspZ as a Protective Target against Multistrain, Tick-Transmitted Lyme Disease.
    Marcinkiewicz AL; Lieknina I; Yang X; Lederman PL; Hart TM; Yates J; Chen WH; Bottazzi ME; Mantis NJ; Kraiczy P; Pal U; Tars K; Lin YP
    Infect Immun; 2020 Apr; 88(5):. PubMed ID: 32122944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization of mice with Borrelia burgdorferi lp54 gene encoded recombinant proteins does not provide protection against tick transmitted infectious challenge.
    Brandt KS; Gilmore RD
    Vaccine; 2017 Sep; 35(40):5310-5313. PubMed ID: 28867507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delineating Surface Epitopes of Lyme Disease Pathogen Targeted by Highly Protective Antibodies of New Zealand White Rabbits.
    Rogovskyy AS; Caoili SEC; Ionov Y; Piontkivska H; Skums P; Tsyvina V; Zelikovsky A; Waghela SD
    Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31085705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination of horses with Lyme vaccines for dogs induces short-lasting antibody responses.
    Guarino C; Asbie S; Rohde J; Glaser A; Wagner B
    Vaccine; 2017 Jul; 35(33):4140-4147. PubMed ID: 28668566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Borrelia burgdorferi BBA52 is a potential target for transmission blocking Lyme disease vaccine.
    Kumar M; Kaur S; Kariu T; Yang X; Bossis I; Anderson JF; Pal U
    Vaccine; 2011 Nov; 29(48):9012-9. PubMed ID: 21945261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral immunization with recombinant lactobacillus plantarum induces a protective immune response in mice with Lyme disease.
    del Rio B; Dattwyler RJ; Aroso M; Neves V; Meirelles L; Seegers JF; Gomes-Solecki M
    Clin Vaccine Immunol; 2008 Sep; 15(9):1429-35. PubMed ID: 18632920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.